An O-Antigen Glycoconjugate Vaccine Produced Using Protein Glycan Coupling Technology Is Protective in an Inhalational Rat Model of Tularemia

Journal of Immunology Research - Egypt
doi 10.1155/2018/8087916
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

PfRON3 Is an Erythrocyte-Binding Protein and a Potential Blood-Stage Vaccine Candidate Antigen

Malaria Journal
ParasitologyInfectious Diseases
2014English

Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate Against Streptococcus Pneumoniae Serotype 1

ACS Central Science
ChemistryChemical Engineering
2018English

Protective Antigen-Mediated Antibody Response Against a Heterologous Protein Produced in Vivo by Bacillus Anthracis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2000English

An Overview of Familiar Tularemia in Kosovo

European Journal of Internal Medicine
Internal Medicine
2011English

Influenza Virus Hemagglutinin as a Vaccine Antigen Produced in Bacteria.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2014English

Antimicrobial Glycoconjugate Vaccines: An Overview of Classic and Modern Approaches for Protein Modification

Chemical Society Reviews
Chemistry
2018English

Engineering the Campylobacter Jejuni N-Glycan to Create an Effective Chicken Vaccine

Scientific Reports
Multidisciplinary
2016English

Salmonella Flagellin Is Not a Dominant Protective Antigen in Oral Immunization With Attenuated Live Vaccine Strains

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2004English

Protective Effects of Proline–Rich Peptide in a Rat Model of Alzheimer Disease: An Electrophysiological Study

Basic and Clinical Neuroscience
Molecular NeuroscienceNeurologyCellular
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy